Difference b in pathogenesis between non alcohyliver cirrhosis vs aloholic liver vorrhosis
Reading File
Finding Sources
Finding Sources
Searching PubMed
"nonalcoholic fatty liver disease" AND pathogenesis
Searching the Web
AASLD MASLD pathogenesis alcohol associated liver disease pathogenesis
You mean non-alcoholic fatty liver disease related cirrhosis versus alcohol-associated liver cirrhosis.
| Feature | MASLD/MASH-related cirrhosis (formerly NAFLD/NASH) | Alcohol-associated cirrhosis |
|---|---|---|
| Primary trigger | Metabolic dysfunction: obesity, insulin resistance/type 2 diabetes, dyslipidemia | Chronic harmful alcohol intake |
| Initial liver injury | Insulin resistance increases fatty-acid delivery and new fat formation in hepatocytes | Ethanol is metabolized to acetaldehyde and acetate |
| Fat accumulation | Excess triglyceride accumulation due to increased lipolysis, hepatic lipogenesis, and impaired fatty-acid oxidation/export | Increased NADH from alcohol metabolism inhibits fatty-acid oxidation and promotes triglyceride synthesis |
| Key toxic mechanism | Lipotoxicity from free fatty acids and toxic lipid species, mitochondrial dysfunction, oxidative and ER stress | Acetaldehyde toxicity, oxidative stress from CYP2E1, mitochondrial injury, and lipid peroxidation |
| Inflammation | Injured hepatocytes activate Kupffer cells and inflammatory pathways; gut microbiome changes may contribute | Alcohol increases intestinal permeability. Bacterial LPS reaches the liver and activates Kupffer cells via TLR4, with TNF-alpha and other cytokines |
| Fibrosis | Persistent lipotoxic inflammation activates hepatic stellate cells, causing collagen deposition and fibrosis | Acetaldehyde, oxidative injury, cytokines, and inflammation activate stellate cells, causing fibrosis |
| Progression | Steatosis -> MASH (steatohepatitis) -> fibrosis -> cirrhosis | Fatty liver -> alcohol-associated hepatitis/steatohepatitis -> fibrosis -> cirrhosis |
| Typical associations | Central obesity, diabetes, hypertension, high triglycerides | Heavy drinking, malnutrition, genetic susceptibility; obesity and diabetes accelerate injury |
One-line difference
- MASLD/MASH cirrhosis: metabolic insulin resistance causes lipotoxic fat accumulation and chronic inflammation.
- Alcohol-associated cirrhosis: ethanol metabolism produces acetaldehyde, excess NADH, and oxidative stress, plus gut-derived inflammatory activation.
Important similarity
Both ultimately converge on the same final pathway:
Hepatocyte injury -> inflammation -> hepatic stellate-cell activation -> collagen deposition -> bridging fibrosis -> cirrhosis.
They can coexist. Alcohol use together with obesity/diabetes often causes more rapid fibrosis progression. NAFLD is now termed MASLD under newer nomenclature, as described by AASLD; alcohol-associated liver disease spans steatosis through cirrhosis according to AASLD guidance.
This is a shared conversation. Sign in to Orris to start your own chat.